UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_____________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
December 31, 2003
Date of Report (date of earliest event reported)
_____________________
VENTANA MEDICAL SYSTEMS, INC.
(Exact name of Registrant as specified in its charter)
State of Delaware 000-20931 94-2976937
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation or organization) Identification Number)
1910 Innovation Park Drive
Tucson, AZ 85737
(Address of principal executive offices)
(520) 887-2155
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
--------------------------------------------------------------------------------
Item 7. Financial Statements and Exhibits
(c) Exhibits
Exhibit No. Description
-------------- ---------------------------------------------------------------
99.1 Press Release, dated as of February 20, 2004
Item 9. Regulation FD Disclosure (pursuant to Item 12)
In accordance with Securities and Exchange Commission Release No. 33-8216,
the following information, which is intended to be furnished under Item 12,
"Results of Operations and Financial Condition," is instead being furnished
under Item 9, "Regulation FD Disclosure." This information shall not be deemed
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), or incorporated by reference in any filing under
the Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing.
On February 20, 2004, Ventana Medical Systems, Inc. ("Ventana") issued a
press release regarding Ventana's results of operations for the quarter ended
December 31, 2003, and disclosing material non-public information. The press
release is attached hereto as Exhibits 99.1 and is incorporated herein by
reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned, thereunto duly authorized.
VENTANA MEDICAL SYSTEMS, INC.
By: / s / NICHOLAS MALDEN
---------------------
Nicholas Malden
Senior Vice President, Chief
Financial Officer and Secretary
Date: February 20, 2004